Quantcast

Latest Ventricular assist device Stories

2014-06-03 16:25:02

FRAMINGHAM, Mass., June 3, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the William Blair & Company 34(th) Annual Growth Stock Conference at 4:10 p.m. CDT (5:10 p.m. EDT) on Tuesday, June 10, 2014. The conference is being held June 10-12 at the...

2014-06-03 08:32:48

PLEASANTON, Calif., June 3, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in three upcoming investor conferences. On Tuesday, June 10, the company will participate in the Goldman Sachs 35(th) Annual Global Healthcare Conference. Gary F. Burbach, President and Chief Executive Officer, will provide an update on the...

2014-05-29 12:25:40

Heart Failure Remains an Area of Focus for Physicians, Facilities and Manufacturers, According to Findings from Decision Resources Group BURLINGTON, Mass., May 29, 2014 /PRNewswire/ -- Decision Resources Group finds that the U.S. cardiac assist device market has gained traction in recent years with product innovations, particularly among ventricular assist devices (VADs), commonly known in the media as LVADs. There are currently limited treatment options for patients with acute heart failure...

2014-05-20 04:21:05

When All Other Treatments Fail, the SynCardia Total Artificial Heart Can Save the Sickest of the Sick. The Freedom Portable Driver Allows a Majority of SynCardia Patients to be Discharged from the Hospital to Live at Home & Get In Better Shape for Their Heart Transplant. TUCSON, Ariz., May 20, 2014 /PRNewswire/ -- SynCardia Systems, Inc. announced today that a United States patient with end-stage biventricular heart failure received the 1,300th implant of the SynCardia temporary...

2014-05-09 08:26:52

FRAMINGHAM, Mass., May 9, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Bank of America Merrill Lynch 2014 Health Care Conference at 12:00 p.m. PDT (3:00 p.m. EDT) on Tuesday, May 13, 2014. The conference is being held May 12-15 at the Encore at...

2014-05-03 23:03:05

On April 29, the FDA announced the recall (class I) of Heartware Ventricular Assist System as the locking mechanism of pump driveline connector may fail to engage. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) May 02, 2014 AttorneyOne.com, a recognized authority on law, updates the website daily regarding all the latest information from the FDA on safety alerts for medical devices....

2014-05-01 08:34:23

FRAMINGHAM, Mass., May 1, 2014 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR), today issued a voluntary Urgent Medical Device Correction related to all HeartWare(®) Ventricular Assist System batteries, product codes 1650 and 1650-DE. In letters to clinicians and patients, the company reports an observed increase in complaints related to earlier-than-expected battery depletion and routine battery handling. HeartWare is providing information to assist patients and clinicians in...

2014-04-30 16:31:17

PLEASANTON, Cailf., April 30, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Bank of America Merrill Lynch 2014 Healthcare Conference on Tuesday, May 13. Gary F. Burbach, President and Chief Executive Officer, will provide an update on the company, beginning at 3:00 p.m., Pacific Daylight Time (6:00 p.m., Eastern...

2014-04-28 16:30:48

LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: US Cardiac Surgery and Heart Valve Devices Markethttp://www.reportbuyer.com/pharma_healthcare/medical_devices/us_cardiac_surgery_heart_valve_devices_market.html The U.S. market for Cardiac Surgery and Heart Valve Device s will grow at a CAGR of 9.5% over theforecast period.The U.S. market for Cardiac Surgery and Heart Valve Device s is being sustained by the stability oftraditional...

2014-04-28 10:11:32

Large sections of the genome that were once referred to as “junk” DNA have been linked to human heart failure, according to research from Washington University School of Medicine in St. Louis. So-called junk DNA was long thought to have no important role in heredity or disease because it doesn’t code for proteins. But emerging research in recent years has revealed that many of these sections of the genome produce RNA molecules that, despite not being proteins, still have important...


Latest Ventricular assist device Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »
Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related